Conferences on Biomaterial-2021....

Scientific Board

Prof. Dr. Mansoori G Ali

University of Illinois
Professor Emeritus
USA

Prof. Dr. Ephraim Suhir

Portland State University
USA

Prof. Dr. Wei Min HUANG

Nanyang Technological University
Singapore

Dr. Nadia Benkirane

French National Institute for Health and Medical Research
France

Prof. Dr. Muhammad T. Afzal

University of New Brunswick
Canada

Prof. Dr. Khamis Hassan

Global Dental Center
Canada

Prof. Dr. Gobinda C. Saha

University of New Brunswick
Canada

Prof. Dr. Alexander L. Kalamkarov

Dalhousie University
Canada

Dr. El Hadji Seydou MBAYE

Aristide Le Dantec Hospital
France

Prof. Dr. Feng Huei

National Cheng Kung University
Taiwan

Prof. Dr. Oluwaseun John Dada

Professorial Chair of Signature Ecosystems Technologies
Hongkong

Prof. Dr. Faeq Radwan

Near East University
Turkey

Prof. Dr. Norma A R Vazquez

Technological Institute of Aguascalientes
Mexico

Prof. Dr. Ivan Chodak

Slovak Academy of Sciences
Slovakia

View All

Aim

Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biomaterials.

Objective

To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Biomaterials.

Dates to remember

Abstract Submission
April 22, 2021
Early Bird Registration
April 26, 2021
Conference Dates
November 08-10, 2021

About Conference

Welcome to Biomaterials-2021!!!

On behalf of the Organizing and Program Committees we take great pleasure in welcoming academic scientists, researchers, research scholars, students and experts of application fields to Frankfurt, Germany for the Global Conference on Biomaterials to foster the progress in the field by contributing with your expertise to what promises to be a very comprehensive and exciting meeting, and to enjoy the immense unique artistic heritage and wonderful landscape of Germany.

Global Conference on Biomaterials (Biomaterials-2021), which will be held during November 08-10, 2021 Frankfurt, Germany is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Global Conference on Biomaterials and related research and latest developments. The event will have 5-6 world level (Highly cited class) plenary speakers, established Keynote speakers, active Invited speakers and fresh contributed speakers. In addition, variety of poster presentations along with workshops and special sessions would be interested in audience.

The aim of the Biomaterials-2021 is to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists and engineers by bringing together again the world class researchers, International Communities and Industrial heads to discuss the latest developments and innovations in the fields of Material Engineering.

We sincerely hope that Biomaterials-2021 serves as an international platform for meeting researchers from around the world, widen professional contact and create new opportunities, including establishing new collaborations.

Young Researchers Opportunity:

We make sure to support and motivate 'Young Researchers' by:

• Establishing their academic and professional relationships.
• Improving their morale and confidence of presenting research in an international platform.
• Interacting with expertise in their respective departments.
•Clearing your inhibitions of adjusting to the foreign environment.
•Providing a holistic experience of academic tourism.

We are looking forward to seeing you at November 08-10, 2021 Frankfurt, Germany.

Prof. Alexander L. Kalamkarov | Conference Co-Chair
Director | Smart Materials Centre
Awarded the CANCAM Gold Medal for the “Outstanding contribution in the area of Applied Mechanics”
Canada.

Abstract Guidelines Structure:
1. The acceptable word range for the abstract is 175 – 275 words. The abstracts which do not meet this word limit will be sent back to the author(s) to be revised.
2. Your submission should be in English.
3. We encourage you to send an informative abstract (complete abstract) which is a summary of a paper’s substance including its background, purpose, methodology, results, and conclusion.
4. Please send in a brief biography together with the Abstract.

Abstract Submission:
1. Submit your abstract to biomaterials-2021@pagesconferences.com
2. After successful submission, receipt acknowledging the abstract will be sent via an email within three working days.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

Submit Abstract Register Now

Plenary Speakers

Prof. Dr. Alexander L. Kalamkarov

Dalhousie University
Canada

>> View Biography

Prof. Dr. Thomas Webster

University of Pittsburgh
USA

>> View Biography

Prof. Dr. Richard J Spontak

North Carolina State University
USA

>> View Biography

Prof. Dr. Alexander Seifalian

London Bio-Science Innovation Centre
UK

>> View Biography

Biography

CEO and Professor Nanotechnology & Regenerative Medicine Commercialization Centre (NanoRegMed Ltd) London BioScience Innovation Centre, London, United Kingdom Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for medical and other industrial applications and synthetic graphene-based nanocomposite materials for surgical and medical devices application. He is currently working on the development of facial organs, heart valves and tendons.

Prof. Dr. Maria Vallet Regi

Complutense University of Madrid
Spain

>> View Biography

Prof. Dr. Avi Domb

Hebrew University
Israel

>> View Biography

Prof. Dr. AharonGedanken

Bar-Ilan University
Israel

>> View Biography

Keynote Speakers

Prof. Dr. Cheryl Miller

The University of Sheffield
UK

>> View Biography

Prof. Dr. Jinlian Hu

City University of Hong Kong HKSAR
China

>> View Biography

Dr. Laís S. Munari

Federal University of Minas Gerais
Brazil

>> View Biography

Prof. Dr. Dimitrios I. Fotiadis

University of Ioannina
Greece

>> View Biography

Biography

Prof. Dimitrios I. Fotiadis (Male), received the Diploma degree in chemical engineering from the National Technical University of Athens, Athens, Greece, and the Ph.D. degree in chemical engineering and materials science from the University of Minnesota, Minneapolis. He is currently a Professor of Biomedical Engineering in the Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece, where he is also the Director of the Unit of Medical Technology and Intelligent Information Systems, and is also an Affiliated Member of Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology, Dept. of Biomedical Research. He was a Visiting Researcher at the RWTH, Aachen, Germany, and the Massachusetts Institute of Technology, Boston. He has coordinated and participated in more than 250 R&D funded projects (in FP6, FP7, H2020, and national Projects), being the coordinator (e.g. INSILC, TAXINOMISIS, HOLOBALANCE, DECODE, etc.) and Technical coordinator (e.g. SMARTOOL, KARDIATOOL, TO_AITION, etc.). He is the author or coauthor of more than 300 papers in scientific journals, 500 papers in peer-reviewed conference proceedings, and more than 50 chapters in books. He is also the author/editor of 30 books. His work has received more than 16,000 citations (h-index=64). He is IEEE EMBS Fellow, EAMBES Fellow, Fellow of IAMBE, member of the IEEE Technical Committee of information Technology in Healthcare, Editor in Chief of IEEE Journal of Biomedical and Health Informatics, Member of the Editorial Board in IEEE Reviews in Biomedical Engineering, Associate Editor for IEEE Open Journal in Engineering in Biology and Medicine and Computers in Biology and Medicine. His research interests include multiscale modelling of human tissues and organs and implantable devices, intelligent wearable/implantable devices for automated diagnosis, processing of big medical data, machine learning, sensor informatics, image informatics, and bioinformatics. He is the recipient of many scientific awards including the one by the Academy of Athens. He is the co-founder of PD Neurotechnology Ltd, UK.

Prof. Dr. Andrey Nikolaevych Belousov

Kharkov Medical Institute
Ukraine

>> View Biography

Biography

Prof. Andrey Nikolaevych Belousov graduate from Kharkov Medical Institute in 1988. Doctor of Medicine degree on speciality - An¬esthesiology and Intensive Care since 2004. The title dissertation: “Extracorporalhemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales dis¬eases”.Author a new medecine products– nanotechnology preparations based on magnetite nanoparticles (Fe3O4) of the size 6-12 nm(www.nanolab.com.ua): the peroral form - Micromage-B (the biologically active additive officially registration in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application –ICNB (intracorporal nanosorbent). A.N. Belousov is author new method of extracorporalhemocorrection using magnet-controlled sor¬bent (MCS-B). Author a new program for estimation degree the severity of the patient. Based on previously developed a universal analytical system of the physiological state of the body (PHUAS) by the author proposed a new automatic program objective assessment of the severity of the patient's condition. Overall, the program can improve health of the population in terms of underfunding by the rapid and objective examination of a large quantity of people. Early on, with the help of the developed program is made possible among surveyed identify risk groups in the severity of general condition, to determine the optimal and effective options for prevention and treatment, saving time and money for the survey, use the data to correlate them with various factors influence of the environment (ecology, nutrition, addictions, drug, vaccine, methods of intensive therapy, pharmacotherapy, etc.).The published more 240 scientific works on results application of nanotechnology preparation in experimental and practical medicine. He has got 7 patents for the invention. Author of the scientific film which focuses on the elaborationof artificial liver device and the development of a new direction in medicine –Nanotechnology.Andrey Belousov was awarded Medical Diploma of Europe “An Honorary Scholar Europe” and R. Koch medal for the scientific achievements, development of a new direction in medicine and elaboration of new method of treatment by means preparations of nanotechnology in 2008. Member of the Ukrainian and Russian Society Nanotechnology. Editor-in-Chiefof International Journal of Biotechnology and Biochemistry,ArvinMed International PTY LTD, Australia;Editor of the Clinical Pharmacology and Toxicology Journal,iMedPub LTD, London, UK;Editorial for the Journal of Clinical Research in Pain and Anaesthesia (JCRPA),Chembio Publishers, LLC, Troy, USA;Advisory Board Members Acta Scientific Medical Sciences, India;Assistant editor-in-chief of the journal ArchivesofBloodTransfusion&Disorders (ABTD), CrimsonPublishers, LLC, NewYork, USA; EditorialBoardNanosensorsandNanomaterialsJournalOscineGroupPvtLtd., NearManyataEmbassy, Bangalore-India; Editorial BoardJournal Current Trends in Bioavailability, London, United Kingdom; Editorial BoardInternational Journal of Anaesthesia& Research, SciTech Central Inc. Walnut. USA; Associate Editors Medical Journal of Clinical Trials & Case Studies, Troy, USA; Editorial Board Member in “Open Access Journal of Oncology (OAJOY)”, Troy, USA;Editorial Board “American Journal of Nano Research and Applications” Science Publishing Group. NEW YORK, U.S.A.; Editorial Board Nanomedicine & Nanotechnology Open Access (NNOA),Medwin Publishers, Troy, USA; Editorial Board Journal “Biomedicine and Therapeutics (BMT)”, Open Access Text, United Kingdom;Editorial Board JournalArchives in Biomedical Engineering & Biotechnology. Iris Publishers, LLC. USA;Editorial Board Journal Integrative Pharmacology and Clinical Science. Open Access Text, London, UK; Editorial Board Journal of Pharmaceutical Sciences. Acta Scientific, India; Editorial Board Journal of Genetic Engineering and Biotechnology Research.Opast Group LLC .USA.Editorial Board of International Journal of Clinical Case Studies & Reports. SciTech Central Inc.USA; Editorial Board of Journal of Clinical Research in Pain and Anaesthesia. Medwin Publishers. Chembio Publishers. Troy, USA.At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies of Belousov in Ukraine, DM, Professor of Department Anesthesiology, Intensive Care, Transfusiology and Hematology Kharkov Medical Academy of Postgraduate Education.